FRA7G is an aphidicolin-inducible common fragile site at human chromosomal band 7q31.2. This region is frequently altered in a number of dierent tumor types including prostate, breast, and ovarian cancer. It has also been hypothesized that this region contains an important tumor suppressor gene which is mutated during the development of these cancers or an oncogene which is ampli®ed. We previously used a FISH-based approach to isolate YAC clones which spanned FRA7G. In this report, we describe the isolation and restriction endonuclease mapping of three overlapping P1 clones which cover FRA7G and the region frequently altered in the dierent cancers. FISH-based analysis of these clones reveals that aphidicolin-induced breakage in the FRA7G region occurs over a region of at least 300 Kb in length. We have also localized a previously sequenced BAC clone to this region. The sequence obtained from this clone reveals the presence of an endogenous retroviral sequence (HERV-H) in the midst of the FRA7G region as well as sequences with homology to small polydispersed circular DNAs (spcDNAs). Thus for the ®rst two cloned common fragile sites, FRA7G and FRA3B, there is an association with both spcDNAs and hot-spots for viral integration.
Introduction
Fragile sites are chromosomal regions that form nonrandom gaps or breaks when exposed to speci®c chemicals or growth conditions (Sutherland and Hecht, 1985) . The relative frequency that a speci®c fragile site is observed in the general population allow for further subclassi®cation of the fragile sites. Fragile sites that are observed in less than 5% of the population are referred to as rare fragile sites, whereas fragile sites that are observed in most individuals are known as common fragile sites. The speci®c chemical or growth condition which promotes fragile site expression allows for further groupings of the rare and common fragile sites.
To date, six rare fragile sites and one common fragile site have been cloned and characterized. Five folate-sensitive rare fragile sites have been cloned, FRAXA, FRAXE, FRAXF, FRA16A, and FRA11B, and each contain a CGG repeat which is ampli®ed and methylated in individuals that demonstrate fragility at these sites (Verkerk et al., 1991; Knight et al., 1993; Ritchie et al., 1994; Jones et al., 1994; Nancarrow et al., 1994) . The sixth cloned rare fragile site is FRA16B. This fragile site is induced by distamycin A, not by folate de®ciency, and contains an expanded 33 bp ATrich minisatellite sequence in individuals expressing the fragile site (Yu et al., 1997) . FRA3B is the only common fragile site which has been characterized at the molecular level Rassool et al., 1996; Wilke et al., 1996; Boldog et al., 1997) . This fragile site is an aphidicolin-sensitive fragile site (Glover et al., 1984) , and the most highly inducible fragile site in the human genome (Smeets et al., 1986) . Breakpoints in FRA3B occur over a region of at least 300 Kb of DNA . Sequence analysis of 110 Kb of DNA from the FRA3B region revealed no information as to why this region is unstable to aphidicolin treatment (Boldog et al., 1997) ; however, it is de®nitely not due to unstable trinucleotide or minisatellite repeat sequences. DNA sequence analysis of the FRA3B region did reveal several interesting features of the region. The ®rst is the presence of an HPV16 viral integration site in the middle of the region of greatest aphidicolin-induced sensitivity . There are also three THE1 elements in the FRA3B region as well as sequences with homology to small polydispersed circular DNAs (spcDNA) (Boldog et al., 1997; Wang et al., 1997) .
Although the molecular basis for instability in the rare fragile site regions is largely unknown, their fragility appears to be associated with expansions of the CGG or minisatellite sequences for each of the cloned rare fragile sites. Much less is known about why sequences within and surrounding the common fragile sites are sensitive when cells are exposed to aphidicolin. One possible explanation is the fragile sites replicate very late in the cell cycle and speci®c conditions which slow this replication eectively inhibit the ability of the common fragile site regions to complete their replication prior to cellular division (Laird et al., 1987) . Preliminary studies with clones throughout the FRA3B region have demonstrated that sequences in the fragile site region are indeed late replicating and that aphidicolin treatment can slow this replication even further (LeBeau et al., 1998) . However, late replication by itself cannot explain why fragile site regions show gaps and breaks after induction as there are many late replicating regions of the genome which do not show this sensitivity.
The association between fragile sites and disease is poorly understood, with the exception of a few of the rare fragile sites. The rare fragile site FRAXA is associated with the most common form of mental retardation Oberle et al., 1991; Verkerk et al., 1991; Yu et al., 1991) , and FRAXE is associated with a milder form of mental retardation (Knight et al., 1993) . FRA11B is located in the CBL2 proto-oncogene region and evidence now exists that breakage at 11q23.3 (the band containing FRA11B) in humans can give rise to a constitutional chromosomal deletion (11q-) resulting in Jacobsen's syndrome Penny et al., 1995) . This association shows that fragile sites can cause instability in vivo and lead to chromosome breakage. Yunis and Soreng (1984) ®rst proposed that the position of the fragile sites corresponds to regions that showed frequent rearrangements and deletions during carcinogenesis. FRA3B is frequently deleted in multiple tumors (Rassool et al., 1992; Kastury et al., 1997; Pandis et al., 1997; Shridhar et al., 1997) and lies very close to the hereditary renal cell carcinoma translocation breakpoint (Cohen et al., 1979; Boldog et al., 1994; Paradee et al., 1996) . Recently, the FHIT gene was identi®ed which crossed the hereditary renal cell carcinoma translocation breakpoint and the FRA3B region (Ohta et al., 1996) and was found to have aberrant transcripts in 50% of gastrointestinal cancers (Ohta et al., 1996) , 80% of small-cell lung cancers, and 40% of non-small cell lung cancers (Sozzi et al., 1996) . Thus, FRA3B appears to be responsible for genomic instability in this region during carcinogenesis and also contains a putative tumor suppressor gene which may play a role in cancer development.
Loss of heterozygosity (LOH) of microsatellite markers at human chromosomal band 7q31.2 has been detected in many solid tumors (Kuniyasu et al., 1994; Zenklusen et al., 1994a Zenklusen et al., , 1995a Champeme et al., 1995; Takahashi et al., 1995; Lin et al., 1996; Devilee et al., 1997) . A recent FISH-based study of prostate cancer revealed triplication of this region (Jenkins et al., manuscript in preparation) . This band also contains the common fragile site FRA7G. We previously reported on this isolation of three YAC clones which covered FRA7G (Huang et al., 1998) . These YACs also contained the markers most frequently lost in breast, prostate, and ovarian cancer (Huang et al., 1998) . Here we report the further localization of FRA7G to a region of at least 300 Kb surrounding the microsatellite D7S522. A P1 contig was constructed which covers the FRA7G region. We have also mapped a BAC clone, which has been completely sequenced, to this region. This clone, RG30H15, localizes near the center of frequent breakage in FRA7G. The sequence of this BAC reveals that FRA7G contains a human endogenous retroviral sequence. In addition, we found that FRA7G, like FRA3B, contains sequences with homology to small polydispersed circular DNAs (spcDNA).
Results

Restriction mapping of P1 clones in the FRA7G region
In our previous experiments using a FISH-based approach, we identi®ed several YAC clones that spanned aphidicolin-induced decondensation/breakage within FRA7G and de®ned FRA7G to a region surrounding D7S522 and D7S486 (Huang et al., 1998) . We have extended this approach to sublocalize the position of FRA7G by analysing P1 clones from this region.
PCR ampli®cation using primers speci®c for D7S522 and D7S486 identi®ed three P1 clones (see Figure 1a PCR product with D7S522, and P1 clone v193A was identi®ed with primers speci®c for D7S486. We then directly sequenced one end of P1 clone v203C using the T7 primer and this enabled us to develop PCR primers speci®c for that end of the clone. These primers generated the correct sized PCR product using DNA from P1 clones v203C and v193A demonstrating that these clones overlap (data not shown).
We then constructed a restriction map for the three P1 clones after linearizing the clones with PvuI. PvuI cuts the P1 cloning vector at three sites: 1213 bp, 7552 bp, and 10842 bp. When we performed a complete digestion of the three P1 clones with PvuI and the DNA fragments were separated by pulsed-®eld gel electrophoresis, two small bands (which were *6 Kb and *3 Kb, respectively) and one large band (greater than 100 Kb) were observed for each of the clones. Thus, there are no PvuI sites in the P1 clones. Similar analysis with SacII and SgfI revealed these enzymes also did not cleave the genomic DNA from this region.
We therefore linearized the three P1 clones with PvuI and then digested the linearized DNA with various concentrations of BamHI and XhoI to obtain partial digests of the genomic DNA contained within the clones. The digestion products were run on two dierent gels optimized for larger or smaller fragments and transferred to nylon membranes. We then hybridized these membranes with radioactively-labeled probes speci®c for the right and then the left end of the P1 cloning vector. Creation of the entire restriction map for each clone was accomplished by aligning the restriction site information from both the left and right end-speci®c probes. The restriction sites of each P1 clone and the alignment of them are shown in Figure 1b .
DNA isolated from the three P1 clones was digested with various restriction endonucleases, and the resulting restriction fragments were then resolved on agarose gels and transferred to nylon backed membranes. These membranes were hybridized with various oligonucleotides representing several of the potential trinucleotide and minisatellite repeats; none of the oligonucleotides hybridized to the three P1 clones. However, the CGG and CTG oligonucleotides did hybridize to the human androgen receptor cDNA in these experiments. Thus, the FRA7G region does not contain any of the repeats represented in the oligonucleotides used.
BAC clone, RG30H15, is derived from this region and has been completely sequenced Our strategy for the characterization of the FRA7G region was to isolate clones covering this region, map them and then sequence them so that we could compare the sequence in the FRA7G region to the sequence already generated in the FRA3B region. However, a search of GenBank revealed that there was a BAC clone, RG30H15, which is derived from this region (this BAC clone was identi®ed using D7S522) which had already been completely sequenced (GenBank Accession number AC002066). The complete sequence for this BAC clone enabled us to alight this BAC clone relative to the three P1 clones v203B, v203C, and v193A. The sequence obtained for RG30H15 also con®rmed the restriction mapping of P1 clones v203B and v203C. Figure 1b shows the alignment of this BAC clone relative to the three P1 clones.
Based upon the sequence information of the BAC clone, we found there was a tetranucleotide repeat (AGGA) 11 near the distal end of this BAC. We constructed primers¯anking this repeat and found that the repeat is highly polymorphic. Five dinucleotide repeats were also found in this BAC clone. Positions of these repeats are shown in Figure 1c . Primers have been constructed¯anking the dinucleotide repeats and determination of polymorphism of these repeats in the human population are ongoing in our laboratory. These repeats should be very useful for the characterization of chromosomal loss in this region in various cancers. The BAC clone also contains other interesting repeats such as THE1, MER, and long L1 sequences (Figure 1c) .
The sequence information for the BAC clone also revealed two very interesting sequences present in this region. We found a 5.8 Kb human endogenous retroviral sequence beginning at nucleotide position 33870 within RG30H15 (Figure 1c ). This sequence was found to be 92.2% homologous to the human retroviral sequence HERV-H (GenBank Accession Number M18048). We also observed a sequence that was highly homologous to small polydispersed circular DNA (spcDNA) (GenBank X96885) beginning at nucleotide position 148040 within RG30H15 ( Figure  1c ). This may be very important as spcDNA sequences have been observed in the 110 Kb of sequence obtained within the FRA3B region (Boldog et al., 1997) . Figure  2 shows a FASTA alignment between spcDNA clone 1-82 (HS182S), and spcDNA sequences obtained in the regions containing FRA3B and FRA7G. We found a 73.2% identity between spcDNA clone 1-82 and FRA7G (Figure 2a) , and a 75.1% identity between an spcDNA sequence within FRA3B and the one identi®ed in BAC RG30H15 (Figure 2b ). There were no trinucleotide or minisatellite repeats present in the sequence from this BAC clone. This provides further evidence that repeats similar to those found at rare fragile sites are probably not responsible for fragility at the common fragile sites.
FISH-based analysis of P1 and BAC clones relative to FRA7G
FISH-based analysis within 3p14.2 revealed that breakage within the FRA3B region occurs over a region of at least 300 Kb Wang et al., 1997; Zimonjic et al., 1997) . Cosmids in the middle of this region would hybridize proximal, distal, or across the region of aphidicolin-induced breakage in dierent metaphases at approximately equal frequencies. The center of this region of breakage was found to contain an HPV16 viral integration site, thus linking instability within a fragile site with a region that would preferentially integrate exogenous viral sequences.
We were therefore interested in analysing the FRA7G region to determine if breakage occurred over a large region and to de®ne the apparent center' of such a region. The three P1 and one BAC clone were thus used as FISH-based probes against aphidicolin-induced FRA7G breakpoints to determine the frequency that they would hybridize proximal, distal, or actually cross the region of breakage. The ®rst clone analysed was P1 clone v203B. When this clone was hybridized to 20 metaphases containing FRA7G breakpoints, it hybridized distal to the region of breakage in 16 metaphases. However, in two metaphases this P1 clone hybridized proximal to the region of breakage and in two metaphase it hybridized across the region of breakage. This demonstrates that breakage occurs over a relatively large region, but that this clone is clearly distal to the region where the majority of aphidicolin-induced breakage occurs.
P1 clone v203c, which is localized proximal to v203B, was hybridized to 31 metaphases that had FRA7G breakpoints. This clone hybridized proximal to the aphidicolin-induced breakpoint in 8 metaphases, distal in 13 metaphases, and crossed the region of breakage in 10 metaphases. P1 clone v193A, the most proximal of the clones analysed, was hybridized to 41 metaphases containing FRA7G breakpoints. This clone hybridized proximal to the aphidicolin-induced breakpoint in 26 metaphases, crossed the breakpoint in 9 metaphases, and hybridized distal in 6 metaphases. Finally BAC clone RG30H15, which covers most of P1 clone v203B and contains additional proximal sequences, was hybridized to 22 metaphases with FRA7G breakpoints. This clone hybridized proximal to the aphidicolin-induced breakpoint in 2 metaphases, crossed the breakpoint in 6 metaphases, and hybridized distal to the breakpoint in 14 metaphases. The results obtained with the three P1 clones and one BAC clone are very similar to results obtained with clones in the FRA3B region and demonstrate that aphidicolininduced breakage in this region occurs across a region at least 300 Kb in size. All of these results are summarized in Table 1 ; also included on this Table is the dierence between the incidence of probes hybridizing proximal and distal hybridization with each of the clones tested. Figure 3 shows several representative hybridizations to aphidicolin-induced metaphases with breakage in the FRA7G region. Figure 3a shows one of the metaphases hybridized with P1 clone v193A where it can be clearly seen that the clone hybridizes proximal to the region of breakage. Figure 3b shows one of the metaphases hybridized with P1 clone v203B, and here the clone hybridized distal to the region of breakage. Figure 3c shows the result obtained when one of the metaphases was hybridized with P1 clone v203C; this clone clearly hybridized across the region of breakage. Figure 3d shows the R banding of the same metaphase seen in Figure 3c which demonstrates that the chromosome 7 breakage in this particular metaphase occurs in band 7q31.2, which is precisely where FRA7G resides. 
Discussion
The mechanism for the instability of the common fragile sites and the role that these sites play in cancer development is unclear. Based upon the cytogenetic location of the common fragile sites and the position of breakpoints and rearrangements observed throughout the genome in human cancers, Yunis and Soreng (1984) ®rst proposed that the fragile sites could be predisposing the chromosomes to breakage and thus could play a key role in cancer development. The analysis of the sequence for much of FRA3B, the most active of the common fragile sites, has not revealed why the FRA3B region is so unstable. However, the molecular characterization of FRA3B has demonstrated that cancer breakpoints and rearrangements do indeed occur right within the FRA3B region at the molecular level (Boldog et al., 1997; Shridhar et al., 1996 Shridhar et al., , 1997 . We were therefore interested in analysing another common fragile site to determine if a comparison between dierent fragile sites would give insights into their mechanism of instability and also to determine if the position of cancer breakpoints at another fragile site coincided with the precise location of that fragile site. We chose to characterize FRA7G, as alterations in the 7q31.2 region are frequently observed in a number of dierent tumors including breast (Zenklusen et al., 1994a; Lin et al., 1996; Devilee et al., 1997) , prostate (Zenklusen et al., 1994b; Takahashi et al., 1995; Latil et al., 1995 ; Jenkins et al., manuscript in preparation), (Zenklusen et al., 1995b; Koike et al., 1997) . However, the FRA7G fragile site is expressed at considerably lower levels than FRA3B; thus, we concentrated our eorts on a chromosome 7-only somatic cell hybrid. The frequency of expression of FRA7G in this hybrid was not greater than what would have been observed in human lymphocytes, but the ease of identifying the chromosome 7 in the hybrid facilitated our analysis of the large number of metaphases which we needed to examine to ®nd sucient FRA7G breakpoints for our FISH-based analysis. By using a FISH-based mapping approach, we previously de®ned the FRA7G region within three YAC clones in the region surrounding a microsatellite marker that has been described as the most frequently deleted in a number of dierent tumors (Huang et al., 1998) . In order to further characterize FRA7G, we identi®ed three P1 clones from the FRA7G region. Restriction endonuclease mapping of these clones revealed that they overlap. In addition, we found that RG30H15, a BAC clone which has been completely sequenced, localized right in the middle of our P1 contig.
The ®ve cloned folate-sensitive rare fragile sites each contain a CGG repeat which is ampli®ed and methylated in individuals who demonstrate fragility at these sites (Verkerk et al., 1991; Knight et al., 1993; Ritchie et al., 1994; Jones et al., 1994; Nancarrow et al., 1994) . The sixth cloned rare fragile site is the distamycin A-inducible fragile site, FRA16B. This fragile site contains an expanded 33 bp AT-rich minisatellite sequence in individuals that express this site (Yu et al., 1997) . We previously constructed a 350 Kb cosmid contig across the aphidicolin-inducible common fragile site FRA3B and found no evidence for the presence of any trinucleotide repeats in this region . There were also no minisatellite repeats in the 110 Kb of sequence generated in this region by Boldog et al. (1997) . The hybridization of various trinucleotide repeats to the P1 clones from the FRA7G region failed to detect any repeats, and there was no large extended repeat sequence present in the 150 Kb of sequence derived from BAC clone RG30H15. These results suggest that the mechanism of instability in the two cloned common fragile sites, FRA3B and FRA7G, are distinct from the instability which occurs in the rare fragile sites associated with expansions of tri-or mini-satellite repeat sequences.
The results of our FISH-based analysis of aphidicolin-induced breakage in the FRA7G region demonstrate that breakage occurs throughout this region. P1 clone v203B hybridized distal to FRA7G breakpoints in 16 out of 20 metaphases. However, this clone hybridized proximal to FRA7G breakpoints in 2 of 20 metaphases. Conversely, the most proximal P1 clone analysed, v193A, hybridized proximal to FRA7G breakpoints in 26 of 41 metaphases. This clone, however, hybridized distal to FRA7G breakpoints in 6 of 41 metaphases. These results demonstrate that breakage in the FRA7G region extends over a region of at least 300 Kb. This result is identical to the results obtained in the FRA3B region Wang et al., 1997; Zimonjic et al., 1997) . Thus for two of the ®rst cloned and characterized common fragile sites, there does not appear to be any repeat sequences responsible for fragility and aphidicolin-induced chromosomal breakage occurs over a region which is probably greater than 300 Kb. One of the cosmids in our 350 Kb contig surrounding the FRA3B region appears to lie within the center of that fragile site. It is thus very interesting to note that there was an HPV16 viral integration site within that cosmid and a sequence with considerable homology to spcDNA. The sequence obtained from BAC clone RG30H15 reveals the presence of another sequence with considerable homology to spcDNA as well as sequences corresponding to HERV-H DNA.
Evidence has been accumulating that spcDNA is associated with genomic instability in human cells . spcDNAs can also be induced or increased by DNA damaging agents (Cohen and Lavi 1996; Cohen et al., 1997) and inhibitors of DNA synthesis, including the common fragile site inducer aphidicolin (Sunnerhagen et al., 1989) . The presence of sequences with considerable homology to spcDNA right in the middle of two of the common fragile sites may therefore not be coincidental. While it is at present uncertain if spcDNA sequences are a primary cause of fragility in both FRA3B and FRA7G as well as other common fragile sites, it is attractive to speculate that these sequences may play some role in the instability in these regions.
It has been hypothesized that the regions containing fragile sites are late replicating (Laird et al., 1987) . This was ®rst demonstrated for FRAXA by Hansen et al. (1993) . The normal FMR1 alleles replicate late in Figure 4 Histogram of the FISH analysis with P1 and BAC clones. The results are expressed in terms of the percentage of the time that FISH signals of each clone were observed across the region of breakage in FRA7G (black) and the absolute value of the dierence between the percentage of the time that a individual clone hybridized distal or proximal to the gaps or breaks of the fragile site (grey shading). The lower the absolute value of the dierence between the percentage of the time that a clone was distal or was proximal to the region of aphidicolin-induced breakage, the more often the hybridization signal was seen equally on both sides of FRA7G
Characterization of FRA7G with P1 and BAC clones at 7q31.2 H Huang et al S-phase, and this replication is further delayed in this region when there is expansion of the trinucleotide repeat (Hansen et al., 1993) . Aphidicolin is an inhibitor of DNA polymerases a and d; an attractive hypothesis to explain fragility at the common fragile sites is that these regions are also late replicating and the inhibition of replication with aphidicolin further delays this replication resulting in instability in these regions. Using a FISH-based technique, we recently demonstrated FRA3B sequences are indeed late replicating, and that exposure to aphidicolin results in a further delay in the timing of replication (LeBeau et al., 1998) . Studies of DNA replication in the region of the cystic ®brosis gene at 7q31.2 showed that the region immediately proximal to the MET oncogene, which localizes precisely within the FRA7G region (Huang et al., 1997) , is a late replicating region (Selig et al., 1992) . This would support the hypothesis ®rst proposed by Laird et al. (1987) ; however, not all late replicating regions are sensitive to aphidicolin and thus other factors must be playing a role in the exquisite sensitivity of most of the common fragile sites to aphidicolin treatment.
Although there are likely to be many dierent causes of chromosomal fragility, it has been shown in at least one case that a fragile site can correspond to a region of incompletely condensed chromatin (Durnam et al., 1986) . Agents that result in incomplete condensation in speci®c chromosomal regions could potentially explain why fragile sites are genetically recombinogenic and why certain fragile sites serve as preferential targets for viral or plasmid integration (Rassool et al., 1991; Smith et al., 1992; van der Drift et al., 1994) . Wilke et al. (1996) showed that a clone derived from the apparent center of the FRA3B region contains an HPV16 viral integration site. We have recently observed that the viral integration site is a hot spot for homozygous deletion in a number of dierent tumor-derived cell lines . It has been observed that infection of human cells with adenovirus type 2 or 5 induces chromosomal fragility, and the virus infection and aphidicolin treatment have a synergistic eect on the expression of the common fragile sites (Caporossi et al., 1991) ; this synergism suggests that both of these agents are targeting the same sequences within the fragile sites. FRA7G does not have an HPV16 viral integration site, as has been observed for FRA3B, but it does contain an HERV-H sequence. While we do not know if the HERV-H sequence is a major cause of fragility in the FRA7G region or simply a marker for this property, it is attractive to speculate that the common fragile sites are hot spots for the integration of exogenous DNA sequences, especially viral sequences. The association of speci®c types of cancer with viral infection, especially in the case of cervical cancer (Cannizzaro et al., 1988; Wagatsuma et al., 1990) , suggests there may indeed be a direct link between viral integration and the initiation of carcinogenesis.
We now have the reagents in hand to begin to characterize two of the common fragile sites in greater detail. In addition, the maturity of the human genome mapping eorts has facilitated the more rapid cloning of additional common fragile sites. A comparison between a number of the common fragile sites should give greater insights into similarities between these sites and the mechanism of instability in these regions. We are also characterizing chromosome breakpoints in the vicinity of these two common fragile sites in a number of dierent tumor types to determine the role these sites play in chromosome breakage and rearrangements during cancer development.
Materials and methods
Preparation of PAC and BAC DNAs
Three P1 clones (v193A, v203B, and v203C) were obtained from Vysis, Inc. (Downer's Grove, IL). These clones were identi®ed by PCR screening of a P1 library using primers for D7S522 and D7S486. A BAC clone (RG30H15) was purchased from Research Genetics, Inc. (Huntsville, AL). P1 clones were maintained in E. coli strain NS3529 and the BAC clone was maintained in E. coli strain HB101/r. Both P1 and BAC clone DNAs were puri®ed using the protocol recommended by QIAGEN using their QIAGEN-tip 100 column (QIAGEN, Chatsworth, CA). DNA preparations were analysed by agarose gel electrophoresis to be certain that there was no RNA present in the preparations and to assay for the presence of bacterial host DNA.
Restriction endonuclease mapping of the PAC clones
The restriction endonucleases used in these experiments (PvuI, BamHI, XhoI, SacII, SgfI, and EcoRI) were obtained from Promega (Madison, WI). The complete digestion of the P1 vector and partial restriction digestion of the genomic DNA in the P1 clones was performed using the procedure described by MacLaren and Clarke (1996) . PvuI restriction endonuclease (21 units) was added to 70 ml of reaction solution containing 3.5 mg P1 clone DNA. This mixture was then divided into 30 ml, 20 ml, and 20 ml portions in order to perform three serial dilutions of the restriction endonucleases which we wanted to generate partial digestion products. Restriction endonucleases (0.033 units) was added into the 30 ml sample. Ten microliters of this sample was transferred to the ®rst 20 ml sample and mixed and then 10 ml of this mixture was transferred to the second 20 ml sample. All samples were then incubated at 378C for 1 h and then mixed with 56 type 1 gel loading buer (Sambrook et al., 1989) . A 10 ml portion of each digested sample was fractionated by pulsed ®eld gel electrophoresis on a 30-lane 1% agarose gel in 0.56TBE buer (Sambrook et al., 1989) . The gel was run for 7 h with a linear ramp from 0.1 to 3.5 s for small fragments, and 17 h with a linear ramp from 0.2 to 9 s for large fragments. All the molecular weight standards were from Gibco-BRL (Gaithersberg, MD).
Southern blot analysis
DNA fragments were transferred to Hybond-N (Amersham) membranes using the downward blotting protocol (MacLaren and Clarke, 1996) . Gels were not compressed with any weight. This method improves the transfer of large DNA fragments and DNA depurination is not necessary. The nylon membranes were washed for 5 min in 26SSC and baked in a vacuum oven at 848C for 2 h. Southern blots were hybridized with random-primer 32 PdCTP labeled probes (410 9 c.p.m./mg) in a phosphate buer-based Church buer at 688C as described by Schifman and Stein (1995) .
Probes from the two ends of the P1 cloning vector were generated from PCR ampli®ed fragments of the P1 vector. The left and right probe primer pairs (pLF, pLB; pRF, pRB) were the pairs described by MacLaren and Clarke (1996).
The PCR products for the left and right end probes were 780 bp and 470 bp, respectively. The PCR conditions to amplify these probes were: Final volume of 50 ml, ®nal concentrations of 16PCR buer (50 mM KCl, 10 mM TrisHCl, 0.1% Triton X-100, 1.5 mM MgCl 2 ) (Promega, Madison, WI), 0.1 mM of each of nucleotide, 1 ng P1 clone DNA, 12.5 pmol of primers, and 3 units Taq DNA polymerase (Promega) were combined. Reactions were cycled 35 times with 30 s at 948C, 30 s at 558C, and 1 min at 728C.
Production of chromosome spreads and induction of FRA7G
The human-hamster hybrid cell line, 1HL11-G, was obtained from the Human Genetic Mutant Cell Repository at the Coriell Institute for Medical Research in Camden, New Jersey (repository number GM10791). This cell line contains a single chromosome 7 as its only human component (Jones et al., 1990; Ledbetter et al., 1990; Green et al., 1991) . Chromosome preparation and fragile site induction were modi®ed from published procedures (Kuwano et al., 1990; Hirsch, 1991; Green et al., 1994) . Brie¯y, cells were cultured in MEM a medium with 10% fetal calf serum, 100 units/ml penicillin, and 100 mg/ml streptomycin. Aphidicolin dissolved in 70% ethanol was added to a ®nal concentration of 0.2 mM and methotrexate (MTX) at a ®nal concentration of 1610
75 M was added 24 h after subculturing. Cultures were further maintained for another 17 h and then the cells were washed twice in Hank's solution, and cultured for another 7 h in medium with BrdU (25 mg/ml) without aphidicolin and MTX. Ethidium bromide (8 mg/ml) and colcemid (0.02 mg/ml) were added for the last 2 h. Cells were then processed using traditional cytogentic procedures for the preparation of metaphase spreads.
PAC and BAC clones used for FISH analysis P1 and BAC clone DNAs were labeled with Biotin-16-dUTP (Boehringer-Mannheim, Indianapolis, IN) using a nick translation kit (Boehringer-Mannheim). Techniques for hybridization of labeled P1 and BAC DNA probes to metaphase spreads and FISH analysis were identical to those described by us previously (Huang et al., 1998) .
Hybridization of trinucleotide and minisatellite repeats to the PAC contig across the FRA7G region Oligonucleotide hybridizations to the PAC clones were performed by labeling oligonucleotides with 32 P-ATP using T4 polynucleotide kinase (Gibco-BRL) and hybridized overnight at 378C to Southern transferred PAC DNA in oligo hybridization solution. The oligonucleotides used in this screening were synthesized by Gibco-BRL or in the Mayo Foundation Molecular Facility Core. These repeats include p(CGG) 11 , p(CTG) 17 , p(ATATATTATATATTA-TATCTAATAATAT C / A TA), p(CTA) 13 , p(TAT) 17 , p(GTA) 14 , p(CCT) 13 , p(TGG) 12 , p(CGT) 14 and p(GAA) 17 . As a positive control we included a cDNA for the human androgen receptor which has a (CGG) repeat and a (CAG) repeat in it.
